Skip to main content
NIH funding notice RFA-AI-20-069

Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional)

Closed on October 13, 2021.

Posted
June 15, 2021
Close date
October 13, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $618,015 in first-year total cost, median $618,015.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 JP-A (M1)]1

Most frequent institutions

  1. UNIV OF NORTH CAROLINA CHAPEL HILL1
Competing awards under RFA-AI-20-069 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Meet me where I am: A multilevel strategy to increase PrEP uptake and persistence among young sexual and gender minority men in rural NC1R61AI174285-01MUESSIG, KATHRYN ERUTSTEIN, SARAH E.UNIV OF NORTH CAROLINA CHAPEL HILL, NC$618,015ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.